Patent Assignment
Reel/Frame 035625/0610
Assignment of Assignor's Interest
Recorded: 2015-05-13
Pages: 17
Assignor
ALCON RESEARCH, LTD.
Executed: 2015-04-20
Assignee
ARROWHEAD RESEARCH CORPORATION
225 SOUTH LAKE AVENUE, SUITE 1050, PASADENA, CALIFORNIA, 91101
Covered Properties
(3)
Rnai-Mediated Inhibition of Phosphodiesterase Type 4 for Treatment of Camp-Related Ocular Disorders
Application:
11/617,604 →
RNAi-Mediated Inhibition of Phosphodiesterase Type 4 for Treatment of cAMP-Related Ocular Disorders
Patent:
8,673,873 →
Application:
12/580,663 →
RNAi-MEDIATED INHIBITION OF PHOSPHODIESTERASE TYPE 4 FOR TREATMENT OF cAMP-RELATED OCULAR DISORDERS
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
May 13, 2015
From: ALCON RESEARCH, LTD.
To: ARROWHEAD RESEARCH CORPORATION
Reel/Frame 035653/0635 →
Security Interest
Aug 7, 2024
From: ARROWHEAD PHARMACEUTICALS, INC.
To: SIXTH STREETLENDING PARTNERS, AS THE ADMINISTRATIVE AGENT
Reel/Frame 068510/0363 →
Change of Name
Aug 12, 2024
From: ARROWHEAD RESEARCH CORPORATION
To: ARROWHEAD PHARMACEUTICALS, INC.
Reel/Frame 068551/0400 →